PATENT CLAIM ANALYSIS

Application Number: 16212723
Application Type: Utility
Filing Date: 2018-12
Publication Date: 2019-04
Patent Classification: ["544", "060000"]

Abstract:
The invention relates to 3-(carboxymethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives, their preparation and their use in medicine, particularly in the treatment of pain.

Claim (Index 29):
The compound according to  claim 1  for use in the treatment of pain.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 98.0
- Lexical Diversity: 1.11111
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['12699451', '11994001', '12604691', '15125615', '15326138']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8411894626813622
- 35 USC 102 Novelty (BERT): 0.5465346841470506
- Combined Prediction Score: 0.8117239848279311
- Mean Citation Score: 400.58527
- Max Citation Score: 437.84778
- Similarity Product: 287.2036719135332

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test